Edmund Liang Chai Ong, Speaker at Infectious Diseases Conferences
Physician

Edmund Liang Chai Ong

Newcastle University Medicine Malaysia, Malaysia

Abstract:

Dengue fever is endemic in more than 100 countries, mainly in the tropical countries and is the most common communicable disease in Malaysia, with an incidence rate of 397.71 per 100,000 individuals. Globally, it is estimated that there are 100-400 million dengue infections annually, with 500,000 cases require hospitalisation each year [WHO, 2024]. The case fatality rate (CFR) of dengue varies significantly across countries, influenced by factors such as healthcare infrastructure and accessibility, timely diagnosis and case management, and vector control measures. Dengue is a systemic and dynamic disease with symptoms ranging from undifferentiated fever to dengue shock syndrome.

A recent published retrospective study (Trop.Med.Infect.Dis.2025,10,30.https://doi.org/10.3390/tropicalmed10020030) led by our research team  will be highlighted which evaluated clinical features and laboratory biomarkers of patients associated with severe dengue at Hospital Sultanah Aminah Johor Bahru, Malaysia admitted from 1st January 2022 to 31st March 2023. Records of 99 patients, categorised into ICU (51) and non-ICU (48) groups, were identified and analysed using SPSS version 28.0. Sociodemographic details, clinical features and laboratory biomarkers were collected. Patients aged 50 and older, with obesity, and pre-existing comorbidities were significantly more likely to be admitted to ICU. The four commonest warning signs in both cohorts were lethargy/ restlessness/confusion, abdominal pain, persistent vomiting and diarrhoea. Fever, or history of fever and thrombocytopenia were the two commonest severe dengue criteria present in both cohorts. ICU patients exhibited more signs of plasma leakage and abnormal laboratory findings, including normal white cell count, hypoalbuminemia, hyperbilirubinemia, and elevated creatine kinase. In contrast, leukopenia and normal albumin, bilirubin, and creatine kinase levels were more common in non-ICU patients. Hyponatremia and raised lactate dehydrogenase were seen in both groups. This study highlighted key differences and similarities in clinical features and laboratory biomarkers between ICU and non-ICU patients, emphasizing the need for further research to develop a comprehensive risk assessment tool for predicting severe dengue that resulted in ICU admission. Key principles of management on severe dengue will be focused and reviewed along with previous published studies.

Biography:

Professor Edmund L. C. Ong is an Infectious Diseases physician and academic who graduated from the University of Newcastle Medical School, UK, and undertook specialist training in Infectious Diseases, Tropical Medicine and General Internal Medicine in the United Kingdom. He is currently a Visiting Professor in Practice at Newcastle University Medicine Malaysia.

His clinical and research interests encompass opportunistic infections, HIV, tuberculosis, dengue and other tropical infections, the evaluation of anti-infective agents, clinical epidemiology, and innovation in healthcare quality improvement and clinical audit.

Professor Ong has served as Principal Investigator and collaborator in numerous international research projects involving HIV, tuberculosis and dengue, with research and clinical collaborations spanning Nigeria, South Africa, Myanmar and Malaysia. He has contributed to several textbooks on infectious diseases and has authored or co-authored more than 200 publications in peer-reviewed scientific journals.

He serves on the editorial boards of several scientific journals, including Tropical Medicine and Infectious Disease and Advances in Medicine and Health Sciences. He is also an experienced examiner for undergraduate and postgraduate medical examinations, including MRCP(UK), the Diploma in HIV Medicine and Master of Medicine (MMed) programmes.

His professional leadership includes serving as International Global Advisor (Malaysia) to the Royal College of Physicians, London, and as former Chair of the British HIV Association (BHIVA) Audit and Standards of Care Committee. He remains actively involved in international medical education, research collaboration and the advancement of clinical standards in infectious diseases.

WhatsApp
Top